News from the healthcare data industry
Nothing like it had ever happened before – a global slowdown in new study starts and a massive decrease in trial accruals for open studies. The turn of events was...
A Q&A with Josh Gagne, Vice President and Global Head of Epidemiology, Johnson & Johnson Innovative new medicines and medical technologies undergo robust safety assessments before they are made available...
The Business Journal spoke with Myerson about his approach to building the health care data company and its latest innovations. Source: https://www.bizjournals.com/seattle/news/2022/11/04/truveta-ceo-terry-myerson-interview.html
There needs to be a bigger emphasis and move towards connecting the life science companies who are doing the work of using biomarkers to develop therapies with the health systems...
RWD can deepen our understanding of patient journeys, reveal important treatment pathways, and demonstrate drug safety and efficacy under complex circumstances. But how much do you know about the standards...
In a recent wide-ranging interview with Healthcare Innovation, Johnston Thayer, M.B.A., R.N., director of clinical informatics and population health at Epic, described a new tool the company is getting ready to pilot...
Connected devices are essential for the advancement of remote patient monitoring. Although medtech devices can be great for gathering data, there are many more steps required to de-silo, convert and...
The Oncology Research Information Exchange Network (ORIEN) has grown to an alliance of 18 cancer centers, powered by the informatics platform of M2GEN, a company that spun out of Florida-based...
Join IQVIA experts as they explore the impact of the Observational Health Data Sciences & Informatics (OHDSI) network in key clinical studies and regulatory decisions, and how IQVIA’s partnership has...
Steven Loeb speaks with Miruna Sasu, President and CEO of COTA, a company that combines oncology expertise with technology and analytics to organize real world data in order to guide decisions...